ADMA
Adma Biologics Inc
Halal Rating :
Last Price
$16.00
Last updated:
Market Cap
-
7D Change
-2.97%
1 Year Change
202.46%
Company Overview
Industries
Exchange
Next Earnings Date
ADMA Biologics Inc is a commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Their primary products are derived from human plasma and used to prevent and treat diseases in immune-compromised individuals and those at risk for certain infectious diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $119.84m | $83.7m | - | $3.5m | 0.00% | 4.18% |
| June 30, 2024 | $107.19m | $71.77m | - | $3.78m | 0.00% | 5.27% |
| March 31, 2024 | $81.88m | $63.82m | - | $3.77m | 0.00% | 5.91% |
Company Impact
Help us evaluate Adma Biologics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.